DIANA NANAYAKKARA: Open Payments
NPI 1710022819 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,962 in 70 payments from 15 companies in 2025. Trend: 2023 $1,741 · 2024 $1,321 · 2025 $1,962
Food & beverage: $1,962
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 21 | $331 |
| Novartis Pharmaceuticals Corporation | 17 | $319 |
| Jenavalve Technology, Inc. | 1 | $257 |
| Regeneron Healthcare Solutions, Inc. | 6 | $216 |
| Novo Nordisk Inc | 9 | $209 |
| Itamar Medical Inc | 1 | $143 |
| Recor Medical Inc | 1 | $117 |
| ABIOMED | 2 | $95 |
| BridgeBio Pharma, Inc. | 3 | $90 |
| Merck Sharp & Dohme LLC | 3 | $59 |
Products named: LEQVIO, REPATHA, EVKEEZA, Wegovy, WatchPATONE, Paradise Ultrasound Renal Denervation System, Attruby, Ozempic.
Industry payments across TX — which companies pay providers there.
